"WuXi AppTec's Transfer of Intellectual Property to China Raises Supply-Chain Risks for US Drug Companies"
TL;DR Summary
US intelligence officials informed Congress that WuXi AppTec transferred a US client's intellectual property to Chinese authorities without consent, raising concerns about the company and other unnamed Chinese firms engaging in activities contrary to US interests.
Topics:business#chinese-authorities#intellectual-property#technology#us-china-relations#us-intelligence#wuxi-apptec
- US intelligence officials told Congress that WuXi transferred IP to Chinese authorities — report Endpoints News
- Exclusive: China's WuXi AppTec shared US client's data with Beijing, US intelligence officials told senators Reuters
- Intelligence officials warned lawmakers WuXi AppTec furnished China with client's intellectual property: Reuters FiercePharma
- U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies The Wall Street Journal
- Anti-China bills portend massive blow to biotech: BioCentury survey BioCentury
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
65%
102 → 36 words
Want the full story? Read the original article
Read on Endpoints News